Get 40% Off
🤯 This Tech Portfolio is up 29% YTD! Join Now to Get April’s Top PicksGet The Picks – Just 99 USD

Universal Health Grows Inorganically, Rising Costs A Drag

Published 12/26/2017, 09:49 PM
Updated 07/09/2023, 06:31 AM

Universal Health Services, Inc.'s (NYSE:UHS) solid inorganic strategy positions it well for long-term growth. The acquisition of the adult services division of Cambian Group and Desert View Hospital in Nevada are worth a mention here.

The company’s top line has been growing consistently since 2006 except for 2012, driven primarily by solid inorganic growth and strong performance from both of its segments — Acute Care and Behavioral Health.

Its acute care platform has been delivering strong underwriting results consistently. The same trend continued in the first nine months of 2017 as well.

In addition, its behavioral platform has been performing well too. In fact, behavioral facility acquisitions help Universal Health win market share in the fast growing addiction and mental health disorder market. The segment continued to deliver strong results in the first nine months of 2017.

Month to date, shares of Universal Health have gained 5.6% while the industry has rallied 4.9%.

However, the stock is currently trading at a trailing 12-month price-to-earnings ratio of 15.3, which is at its median range, the same compares unfavorably with the industry average of 14.9. This suggests that the stock is overvalued compared to its peers.

In addition, the company’s high-debt level has been a concern over the last few years. This also led to a rise in interest expenses which has been putting pressure on its margins.

Another area of concern for the company is the increase in its operating expenses since 2013, which continued to rise in the first nine months of 2017. This also keeps weighing on the company’s bottom line.

Zacks Rank & Stocks to Consider

Universal Health currently has a Zacks Rank #3 (Hold).

Investors interested in the medical sector can consider some better-ranked stocks like Align Technology, Inc. (NASDAQ:ALGN) , Amedisys, Inc. (NASDAQ:AMED) and Cerus Corporation (NASDAQ:CERS) . While Align Technology sports a Zacks Rank #1 (Strong Buy), the other two stocks carry a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.

Align Technology delivered positive surprises in each of the last four quarters, with an average beat of 16.6%.

Amedisys delivered positive surprises in each of the last four quarters, with an average beat of 13.1%.

Cerus Corp delivered positive surprises in three of the last four quarters, with an average beat of 7.8%.

Wall Street’s Next Amazon (NASDAQ:AMZN)

Zacks EVP Kevin Matras believes this familiar stock has only just begun its climb to become one of the greatest investments of all time. It’s a once-in-a-generation opportunity to invest in pure genius.

Click for details >>



Cerus Corporation (CERS): Free Stock Analysis Report

Universal Health Services, Inc. (UHS): Free Stock Analysis Report

Amedisys Inc (AMED): Free Stock Analysis Report

Align Technology, Inc. (ALGN): Free Stock Analysis Report

Original post

Zacks Investment Research

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.